Suppr超能文献

血小板衍生生长因子作为手术辅助手段在压疮治疗中的作用。

Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers.

作者信息

Kallianinen L K, Hirshberg J, Marchant B, Rees R S

机构信息

Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0340, USA.

出版信息

Plast Reconstr Surg. 2000 Nov;106(6):1243-8. doi: 10.1097/00006534-200011000-00001.

Abstract

Management options for pressure ulcers include local wound care, surgical repair, and, more recently, topical application of platelet-derived growth factor (PDGF). PDGF is a glycoprotein that is mitogenic for mesenchymal cells and has been studied extensively for applicability in promoting the healing of chronic human wounds. Using data obtained from a multicenter clinical trial for the treatment of full-thickness pressure ulcers, a subset analysis was performed to investigate the outcome of salvage surgery for pressure ulcers, after incomplete closure occurred with the topical use of either recombinant human PDGF-BB (rhPDGF-BB) or placebo gel. At the University of Michigan Wound Care Center, subset data from a randomized, double-blind, placebo-controlled, parallel group clinical trial were reviewed to compare the effects of three concentrations of rhPDGF-BB on full-thickness pressure ulcers of the trunk with those of the placebo. Twenty-eight patients were enrolled and 27 completed the trial. An intent-to-treat analysis was used to evaluate data. If the ulcer did not heal by the end of the 16-week trial period, the surgeon, still blinded to the treatment group, offered salvage surgical repair of the pressure ulcer. Eleven patients underwent salvage surgical repair using myocutaneous flaps, primary closure, or skin grafts. Of three patients who received placebo followed by surgery, none progressed to full healing within 1 year. Of 12 patients in the treatment group who received rhPDGF-BB and salvage surgery, 11 (92 percent) ultimately healed the ulcers within 1 year after the start of the clinical trial. These findings suggest that treatment with rhPDGF-BB before surgery enhances the ability to achieve a closed wound over surgery alone. It must yet be determined to what degree rhPDGF-BB contributed to the excellent results seen in the rhPDGF-BB/surgery group. It is possible that rhPDGF-BB "primes" the local wound milieu to make it more responsive to complete closure following surgical treatment.

摘要

压疮的治疗选择包括局部伤口护理、手术修复,以及最近采用的血小板衍生生长因子(PDGF)局部应用。PDGF是一种对间充质细胞有促有丝分裂作用的糖蛋白,人们对其在促进慢性人类伤口愈合方面的适用性进行了广泛研究。利用一项治疗全层压疮的多中心临床试验获得的数据,进行了一项亚组分析,以研究在局部使用重组人PDGF-BB(rhPDGF-BB)或安慰剂凝胶后发生不完全闭合的情况下,压疮挽救手术的结果。在密歇根大学伤口护理中心,回顾了一项随机、双盲、安慰剂对照、平行组临床试验的亚组数据,以比较三种浓度的rhPDGF-BB对躯干全层压疮的影响与安慰剂的影响。28名患者入组,27名完成试验。采用意向性分析来评估数据。如果溃疡在16周试验期结束时未愈合,仍对治疗组不知情的外科医生会提供压疮的挽救性手术修复。11名患者接受了使用肌皮瓣、一期缝合或皮肤移植的挽救性手术修复。在接受安慰剂后进行手术的3名患者中,没有一人在1年内完全愈合。在接受rhPDGF-BB并进行挽救性手术的治疗组的12名患者中,11名(92%)在临床试验开始后1年内最终使溃疡愈合。这些发现表明,术前使用rhPDGF-BB治疗比单纯手术更能提高实现伤口闭合的能力。rhPDGF-BB在rhPDGF-BB/手术组中所取得的优异结果中起到了多大作用,仍有待确定。rhPDGF-BB有可能“启动”局部伤口环境,使其对手术治疗后的完全闭合更有反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验